thiazoles has been researched along with Rhabdomyosarcoma 2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abraham, J; Aslam, MI; Druker, BJ; Keller, C; Mansoor, A; Tyner, JW | 1 |
1 other study(ies) available for thiazoles and Rhabdomyosarcoma 2
Article | Year |
---|---|
PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma.
Topics: Animals; Apoptosis; Becaplermin; Benzamides; Cell Adhesion; Cell Proliferation; Cell Survival; Dasatinib; Ephrin-B2; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Protein-Tyrosine Kinases; Forkhead Box Protein O1; Forkhead Transcription Factors; Humans; Imatinib Mesylate; Mice; Paired Box Transcription Factors; Phosphorylation; Piperazines; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Pyrimidines; Receptor Cross-Talk; Receptor, EphB4; Receptor, Platelet-Derived Growth Factor beta; Rhabdomyosarcoma, Alveolar; RNA Interference; RNA, Small Interfering; Signal Transduction; Thiazoles | 2014 |